{
  "data": {
    "indicator": {
      "slug": "phase-i-small-molecule-clinical-trial-share",
      "name": "Phase I small molecule clinical trial share",
      "definition": "Percentage of Phase I clinical trial starts that evaluate small molecule drugs.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2016-01-01",
        "period_label": "2016",
        "value": 72,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCF5037JCNPDKKT7NP2",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP2",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      },
      {
        "period_start": "2016-01-01",
        "period_label": "2016",
        "value": 72,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGCY",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCY",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      },
      {
        "period_start": "2023-01-01",
        "period_label": "2023",
        "value": 60,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCF5037JCNPDKKT7NP3",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP3",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      },
      {
        "period_start": "2023-01-01",
        "period_label": "2023",
        "value": 60,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGCZ",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGCZ",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      },
      {
        "period_start": "2025-01-01",
        "period_label": "2025",
        "value": 62,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCF5037JCNPDKKT7NP4",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NP4",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      },
      {
        "period_start": "2025-01-01",
        "period_label": "2025",
        "value": 62,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGD0",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGD0",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026",
          "locator": "Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 6
  }
}